TGF-β/Smad-signaling in liver cells: Target genes and inhibitors of two parallel pathways

Signal Transduction

Volumn 6, Issue 5, 2006, Pages 329-337

  Breitkopf, Katja ^a,b   Weng, Honglei ^a   Dooley, Steven ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Molecular Alcohol Research in Gastroenterology   (Germany)

Author keywords

ALK 1; ALK 5; Fibrosis; Liver; Smads

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CHRONIC LIVER DISEASE; ENZYME INHIBITION; GENE TARGETING; HUMAN; LIVER CELL; LIVER FIBROSIS; NONHUMAN; PLASTICITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STELLATE CELL;

EID: 33750057700     PISSN: 16154053     EISSN: 16154061     Source Type: Journal    
DOI: 10.1002/sita.200600097     Document Type: Review

References (74)

1. Bissell, D. M., Roulot, D., George, J. (2001) Transforming growth factor β and the liver. Hepatology 34: 859-867.
2. Goumans, M. J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., et al. (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. Embo J. 21: 1743-1753.
3. Yue, J., Mulder, K. M. (2000) Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods Mol. Biol. 142: 125-131.
4. Yue, J., Mulder, K. M. (2001) Transforming growth factor-beta signal transduction in epithelial cells. Pharmacol. Ther. 91: 1-34.
5. Moustakas, A., Heldin, C. H. (2005) Non-Smad TGF-β signals. J. Cell Sci. 118: 3573-3584.
6. Hocevar, B. A., Brown, T. L., Howe, P. H. (1999) TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, Smad4-independent pathway. Embo J. 18: 1345-1356.
7. Itoh, S., Thorikay, M., Kowanetz, M., Moustakas, A., et al. (2003) Elucidation of Smad requirement in transforming growth factor-beta type I receptor-induced responses. J. Biol. Chem. 278: 3751-3761.
8. Dai, C., Liu, Y. (2004) Hepatocyte growth factor antagonizes the profibrotic action of TGF-β1 in mesangial cells by stabilizing Smad transcriptional corepressor TGIF. J. Am. Soc. Nephrol. 15: 1402-1412.
9. Kowanetz, M., Valcourt, U., Bergstrom, R., Heldin, C. H., Moustakas, A. (2004) Id2 and Id3 define the potency of cell proliferation and differentiation responses to transforming growth factor β and bone morphogenetic protein. Mol. Cell. Biol. 24: 4241-4254.
10. Yue, J., Sun, B., Liu, G., Mulder, K. M. (2004) Requirement of TGF-β receptor-dependent activation of c-Jun N-terminal kinases (JNKs)/stress- activated protein kinases (SAPKs) for TGF-β up-regulation of the urokinase-type plasminogen activator receptor. J. Cell Physiol. 199: 284-292.
11. Bakin, A. V., Tomlinson, A. K., Bhowmick, N. A., Moses, H. L., Arteaga, C. L. (2000) Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275: 36803-36810.
12. Massagué, J. (1990) The transforming growth factor-β family. Annu. Rev. Cell. Biol. 6: 597-641.
13. Berg, F., Delvoux, B., Gao, C., Westhoff, J. H., et al. (2002) Divergence of TGF-β signaling in activated hepatic stellate cells downstream from Smad2 phosphorylation. Signal Transduction 2: 11-28.
14. Gressner, A. M. (1996) Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: A key event in hepatic fibrogenesis. Kidney Int. 49: S39-S45.
15. Schnabl, B., Kweon, Y. O., Frederick, J. P., Wang, X. F., et al. (2001) The role of Smad3 in mediating mouse hepatic stellate cell activation. Hepatology 34: 89-100.
16. Lindert, S., Wickert, L., Sawitza, I., Wiercinska, E., et al. (2005) Transdifferentiation-dependent expression of α-SMA in hepatic stellate cells does not involve TGF-β pathways leading to coinduction of collagen type I and thrombospondin-2. Matrix Biol. 24: 198-207.
17. Tsukada, S., Westwick, J. K., Ikejima, K., Sato, N., Rippe, R. A. (2005) SMAD and p38 MAPK signaling pathways independently regulate α1(I) collagen gene expression in unstimulated and transforming growth factor-β- stimulated hepatic stellate cells. J. Biol. Chem. 280: 10055-10064.
18. Uemura, M., Swenson, E. S., Gaca, M. D., Giordano, F. J., et al. (2005) Smad2 and Smad3 play different roles in rat hepatic stellate cell function and α-smooth muscle actin organization. Mol. Biol. Cell 16: 4214-4224.
19. Cao, Q., Mak, K. M., Lieber, C. S. (2002) Dilinoleoylphosphatidylcholine prevents transforming growth factor-β1-mediated collagen accumulation in cultured rat hepatic stellate cells. J. Lab. Clin. Med. 139: 202-210.
20. Knittel, T., Mehde, M., Kobold, D., Saile, E., et al. (1999) Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-β and TGF-β1. J. Hepatol. 30: 48-60.
21. Shibata, N., Watanabe, T., Okitsu, T., Sakaguchi, M., et al. (2003) Establishment of an immortalized human hepatic stellate cell line to develop antifibrotic therapies. Cell Transplant. 12: 499-507.
22. Sauvant, P., Sapin, V., Abergel, A., Schmidt, C. K., et al. (2002) PAV-1, a new rat hepatic stellate cell line converts retinol into retinoic acid, a process altered by ethanol. Int. J. Biochem. Cell Biol. 34: 1017-1029.
23. Vogel, S., Piantedosi, R., Frank, J., Lalazar, A., et al. (2000) An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J. Lipid Res. 41: 882-893.
24. Xu, L., Hui, A. Y., Albanis, E., Arthur, M. J., et al. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142-151.
25. Greenwel, P., Schwartz, M., Rosas, M., Peyrol, S., et al. (1991) Characterization of fat storing cell lines derived from normal and CC14-cirrhotic livers. Lab. Invest. 65: 644-653.
26. Pan, Q., Li, D. G., Lu, H. M., Wang, Y. Q., et al. (2005) A new immortalized rat cell line, hepatic stellate cell-PQ, exhibiting characteristics of hepatic stellate cells. Hepatobiliary Pancreat. Dis. Int. 4: 281-284.
27. Wiercinska, E., Wickert, L., Denecke, B., Said, H. M., et al. (2006) Id1 is a critical mediator in TGF-β-induced transdifferentiation of rat hepatic stellate cells. Hepatology 43: 1032-1041.
28. Dooley, S., Delvoux, B., Lahme, B., Mangasser-Stephan, K., Gressner, A. M. (2000) Modulation of transforming growth factor-beta response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts. Hepatology 31:1094-1106.
29. Dooley, S., Delvoux, B., Streckert, M., Bonzel, L., et al. (2001) Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGF-β signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 502: 4-10.
30. Inagaki, Y., Mamura, M., Kanamaru, Y., Greenwel, P., et al. (2001) Constitutive phosphorylation and nuclear localization of Smad3 are correlated with increased collagen gene transcription in activated hepatic stellate cells. J. Cell Physiol. 187: 117-123.
31. Breitkopf, K., Sawitza, I., Westhoff, J. H., Wickert, L., et al. (2005) Thrombospondin-1 acts as a strong promoter of TGF-β effects via two distinct mechanisms in hepatic stellate cells. Gut 54: 673-681.
32. Breitkopf, K., Roeyen, C. V., Sawitza, I., Wickert, L., et al. (2005) Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors α and β in activated rat hepatic stellate cells (HSC). Cytokine 31: 349-357.
33. Yoshida, K., Matsuzaki, K., Mori, S., Tahashi, Y., et al. (2005) Transforming growth factor-beta and platelet-derived growth factor signal via c-Jun N-terminal kinase-dependent Smad2/3 phosphorylation in rat hepatic stellate cells after acute liver injury. Am. J. Pathol. 166: 1029-1039.
34. Furukawa, F., Matsuzaki, K., Mori, S., Tahashi, Y., et al. (2003) p38 MAPK mediates fibrogenic signal through Smad3 phosphorylation in rat myofibroblasts. Hepatology 38:879-889.
35. Liu, C., Gaca, M. D., Swenson, E. S., Vellucci, V. F., et al. (2003) Smads 2 and 3 are differentially activated by transforming growth factor-β (TGF-β) in quiescent and activated hepatic stellate cells. Constitutive nuclear localization of Smads in activated cells is TGF-β-independent. J. Biol. Chem. 278: 11721-11728.
36. Albano, E., French, S. W., Ingelman-Sundberg, M. (1999) Hydroxyethyl radicals in ethanol hepatotoxicity. Front Biosci. 4: D533-540.
37. Lieber, C. S. (1999) Microsomal ethanol-oxidizing system (MEOS): the first 30 years (1968-1998) - a review. Alcohol Clin. Exp. Res. 23: 991-1007.
38. Fang, C., Lindros, K. O., Badger, T. M., Ronis, M. J., Ingelman-Sundberg, M. (1998) Zonated expression of cytokines in rat liver: effect of chronic ethanol and the cytochrome P450 2E1 inhibitor, chlormethiazole. Hepatology 27: 1304-1310.
39. Muller, G. F., Dohr, O., El-Bahay, C., Kahl, R., Abel, J. (2000) Effect of transforming growth factor-β1 on cytochrome P450 expression: inhibition of CYP1 mRNA and protein expression in primary rat hepatocytes. Arch. Toxicol. 74: 145-152.
40. Batey, R. G., Wang, J. (2002) Molecular pathogenesis of T lymphocyte-induced liver injury in alcoholic hepatitis. Front. Biosci. 7: d1662-1675.
41. Kono, H., Uesugi, T., Froh, M., Rusyn, I., et al. (2001) ICAM-1 is involved in the mechanism of alcohol-induced liver injury: studies with knockout mice. Am. J. Physiol. Gastrointest. Liver Physiol. 280: G1289-1295.
42. Minagawa, M., Deng, Q., Liu, Z. X., Tsukamoto, H., Dennert, G. (2004) Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-α during alcohol consumption. Gastroenterology 126: 1387-1399.
43. Nieto, N., Friedman, S. L., Cederbaum, A. I. (2002) Stimulation and proliferation of primary rat hepatic stellate cells by cytochrome P450 2E1-derived reactive oxygen species. Hepatology 35: 62-73.
44. Krull, N. B., Zimmermann, T., Gressner, A. M. (1993) Spatial and temporal patterns of gene expression for the proteoglycans biglycan and decorin and for transforming growth factor-β1 revealed by in situ hybridization during experimentally induced liver fibrosis in the rat. Hepatology 18: 581-589.
45. Kang, Y., Massague, J. (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell 118: 277-279.
46. Valdes, F., Alvarez, A. M., Locascio, A., Vega, S., et al. (2002) The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor β in fetal rat hepatocytes. Mol. Cancer Res. 1:68-78.
47. Gotzmann, J., Huber, H., Thallinger, C., Wolschek, M., et al. (2002) Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-β1 and Ha-Ras: steps towards invasiveness. J. Cell Sci. 115: 1189-1202.
48. Gotzmann, J., Fischer, A. N., Zojer, M., Mikula, M., et al. (2006) A crucial function of PDGF in TGF-β-mediated cancer progression of hepatocytes. Oncogene 25: 3170-3185.
49. Kanamaru, C., Yasuda, H., Takeda, M., Ueda, N., et al. (2001) Smad7 is induced by norepinephrine and protects rat hepatocytes from activin A-induced growth inhibition. J. Biol. Chem. 276: 45636-45641.
50. Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., et al. (1997) Identification of Smad7, a TGF β-inducible antagonist of TGF-β signalling. Nature 389: 631-635.
51. Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., et al. (1997) The MAD-related protein Smad7 associates with the TGF-β receptor and functions as an antagonist of TGF-β signaling. Cell 89: 1165-1173.
52. Imamura, T., Takase, M., Nishihara, A., Oeda, E., et al. (1997) Smad6 inhibits signalling by the TGF-β superfamily [see comments]. Nature 389: 622-626.
53. Stopa, M., Anhuf, D., Terstegen, L., Gatsios, P., et al. (2000) Participation of Smad2, Smad3, and Smad4 in transforming growth factor β (TGF-β)-induced activation of Smad7. The TGF-β response element of the promoter requires functional Smad binding element and E- box sequences for transcriptional regulation. J. Biol. Chem. 275: 29308-29317.
54. Tahashi, Y., Matsuzaki, K., Date, M., Yoshida, K., et al. (2002) Differential regulation of TGF-β signal in hepatic stellate cells between acute and chronic rat liver injury. Hepatology 35: 49-61.
55. Dooley, S., Hamzavi, J., Breitkopf, K., Wiercinska, E., et al. (2003) Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. Gastroenterology 125: 178-191.
56. Luo, K. (2004) Ski and SnoN: negative regulators of TGF-β signaling. Curr. Opin. Genet. Dev. 14: 65-70.
57. Macias-Silva, M., Li, W., Leu, J. I., Crissey, M. A., Taub, R. (2002) Up-regulated transcriptional repressors SnoN and Ski bind Smad proteins to antagonize transforming growth factor-beta signals during liver regeneration. J. Biol. Chem. 277: 28483-28490.
58. Muir, A. J., Sylvestre, P. B., Rockey, D. C. (2006) Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection. J. Viral. Hepat. 13: 322-328.
59. Weng, H. L., Wang, B. E., Jia, J. D., Wu, W. F., et al. (2005) Effect of interferon-gamma on hepatic fibrosis in chronic hepatitis B virus infection: a randomized controlled study. Clin. Gastroenterol. Hepatol. 3: 819-828.
60. Weng, H., Mertens, P., Gressner, A. M., Dooley, S. (2006) IFN-γ abrogates prefibrogenic TGF-β signalling inliver by targeting expression of inhibitory and receptor smads. 7 J. Hepatol., in press.
61. Dooley, S., Said, H. M., Gressner, A. M., Floege, J., et al. (2006) Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects. J. Biol. Chem. 281: 1784-1795.
62. Inagaki, Y., Kushida, M., Higashi, K., Itoh, J., et al. (2005) Cell type-specific intervention of transforming growth factor β/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 129: 259-268.
63. Hellerbrand, C., Stefanovic, B., Giordano, F., Burchardt, E. R., Brenner, D. A. (1999) The role of TGFβ1 in initiating hepatic stellate cell activation in vivo. J. Hepatol. 30: 77-87.
64. Wells, R. G. (2005) The role of matrix stiffness in hepatic stellate cell activation and liver fibrosis. J. Clin. Gastroenterol. 39: S158-161.
65. Ozawa, S., Uchiyama, K., Nakamori, M., Ueda, K., et al. (2006) Combination gene therapy of HGF and truncated type II TGF-β receptor for rat liver cirrhosis after partial hepatectomy. Surgery 139: 563-573.
66. Qi, Z., Atsuchi, N., Ooshima, A., Takeshita, A., Ueno, H. (1999) Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc. Nat. Acad. Sci. U. S. A. 96: 2345-2349.
67. Ueno, H., Sakamoto, T., Nakamura, T., Qi, Z., et al. (2000) A soluble transforming growth factor β receptor expressed in muscle prevents liver fibrogenesis and dysfunction in rats. Hum. Gene Ther. 11: 33-42.
68. George, J., Roulot, D., Koteliansky, V. E., Bissell, D. M. (1999) In vivo inhibition of rat stellate cell activation by soluble transforming growth factor β type II receptor: A potential new therapy for hepatic fibrosis. Proc. Nat. Acad. Sci. U. S. A. 96: 12719-12724.
69. Okuno, M., Akita, K., Moriwaki, H., Kawada, N., et al. (2001) Prevention of rat hepatic fibrosis by the protease inhibitor, camostat mesilate, via reduced generation of active TGF-β. Gastroenterology 120: 1784-1800.
70. Kondou, H., Mushiake, S., Etani, Y., Miyoshi, Y., et al. (2003) A blocking peptide for transforming growth factor-β1 activation prevents hepatic fibrosis in vivo. J. Hepatol. 39: 742-748.
71. Ueki, T., Kaneda, Y., Tsutsui, H., Nakanishi, K., et al. (1999) Hepatocyte growth factor gene therapy of liver cirrhosis in rats. Nature Med. 5: 226-230.
72. Zhang, L. J., Yu, J. P., Li, D., Huang, Y. H., et al. (2004) Effects of cytokines on carbon tetrachloride-induced hepatic fibrogenesis in rats. World J. Gastroenterol. 10: 77-81.
73. Shi, M. N., Huang, Y. H., Zheng, W. D., Zhang, et al. (2006) Relationship between transforming growth factor β1 and anti-fibrotic effect of interleukin-10. World J. Gastroenterol. 12: 2357-2362.
74. de Gouville, A. C., Boullay, V., Krysa, G., Pilot, et al. (2005) Inhibition of TGF-β signaling by an ALK5 inhibitor protects rats from dimethylnitrosamine-induced liver fibrosis. Br. J. Pharmacol. 145: 166-177.